Publications by authors named "C K Yoshida"

A 59-year-old woman presented with multiple mediastinal masses 6 months after post-thymectomy for type B2 thymoma. A diagnosis of small-cell carcinoma (SmCC) via a computed tomography-guided biopsy and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography revealed no primary lesions outside the anterior mediastinum. The pathologically reevaluated post-thymectomy specimen showed no neuroendocrine differentiation.

View Article and Find Full Text PDF

HM-SCREEN-Japan is a multicenter collaborative project in Japan to evaluate the clinical utility of a cancer genome panel in the treatment of acute myeloid leukemia (AML). The HM-SCREEN-JAPAN02 study used the Amoy Myeloid Panel with the HANDLE system, which enables efficient and rapid sequencing, as the genomic testing kit. The Amoy Myeloid Panel targets 53 genes with established clinical significance or high prevalence.

View Article and Find Full Text PDF
Article Synopsis
  • * A nationwide survey tracked data from 70 pregnancies in 49 CML patients between 2002 and 2020, highlighting three pregnancy types: CML onset during pregnancy, unplanned pregnancies during TKI treatment, and planned pregnancies during treatment-free remission (TFR) or using interferon-alpha (IFN-α).
  • * The study found that planned pregnancies had a longer time from CML diagnosis compared to unplanned ones, and TFR or IFN-α were deemed safe pregnancy options—indicating the need for careful planning for pregnancies in women
View Article and Find Full Text PDF

Introduction: Organophosphate esters (OPEs) are increasing in use as flame retardants and plasticizers and concerns have been raised given their endocrine-disrupting activities and possible obesogenic consequences. However, longitudinal studies on gestational OPE exposure and childhood obesity are scarce. This study examined whether OPE levels in maternal urine during pregnancy were associated with the risk of childhood obesity.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic spurred global efforts to sequence SARS-CoV-2 genomes to monitor its evolution and guide public health decisions, resulting in millions of genome sequences being shared worldwide.
  • The Canadian COVID-19 Genomics Network (CanCOGeN - VirusSeq) launched the Canadian VirusSeq Data Portal to provide open access to genomic sequences and standardized contextual data while adhering to FAIR standards.
  • The portal emphasizes data quality, privacy compliance, and security, and is used alongside tools like Viral AI and the CoVaRR-Net to facilitate ongoing research and analysis of SARS-CoV-2 variants in Canada.
View Article and Find Full Text PDF